Grants and Contributions:
Title:
Next generation technologies to aid medication adherence
Agreement Number:
998468
Agreement Value:
$150,000.00
Agreement Date:
Nov 1, 2022 - Mar 31, 2025
Description:
Poor prescription adherence is a cause in —50% of hospital admissions, causing annual deaths of —125 000 and over $100 billion in annual costs to the healthcare industry1. This project will investigate new technologies to monitor and aid adherence to prescribed medication plans, in order to enable seniors to live longer, healthier and more independent lives. The project will be split into two concurrent work streams (WS). The first WS will focus on development of next generation smart blister packaging. This project builds on almost a decade of expertise in smart packaging at Jones Healthcare Group (JHG), much of which was gained during the Printable Electronics Flagship Program in collaboration with NRC. In particular, JHG now have significant experience in the manufacture, distribution and testing of smart blister packaging, based on a multiple trials performed in recent years. This WS aims to improve manufacturability and add further functionality to smart blister packaging in order to promote adherence and enhance accessibility. The second WS will look at other technologies to aid medication adherence. This will include technologies to monitor liquid medication, as well as methods to monitor other pharmaceutical dispensing technologies. These technologies will enable older adults to live independent lives for longer by improving medication efficiency, reducing hospital admissions, and reassuring family and friends.
Organization:
National Research Council Canada
Expected Results:
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.
Location:
London, Ontario, CA N5V 5H3
Reference Number:
172-2022-2023-Q4-998468
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
891176471
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreement has been modified by 90 days.
Amendment Date
Nov 4, 2024
Recipient's Legal Name:
Jones Healthcare Group Inc.
Federal Riding Name:
London--Fanshawe
Federal Riding Number:
35054
Program:
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Program Purpose:
Collaborate on multiparty research and development programs to catalyze transformative, high-risk, high-reward research with the potential for game-changing scientific discoveries and technological breakthroughs in priority areas.
NAICS Code:
541710
Amendments: